MD Longevity Lab: Playing the Long Game with Drs. Vikas and Nisha Patel

30. The Delay Game: How Health Insurance Abandoned Your Healthcare & Why The Long Game of Prevention Belongs to You

The American health insurance industry is no longer in the business of paying for your healthcare. It is in the business of delaying it — long enough that someone else has to pay. Usually Medicare. Which means you, with your taxes, after you turn 65, sick. In this episode, Drs. Vikas and Nisha Patel pull apart a system most Americans don't understand and would rather not. They walk through the real economics of prior authorization (the most lucrative word in American healthcare), why physicians are quietly leaving private practice, who actually pays when insurance delays your care, and what your insurance will never cover that could genuinely extend your life. This isn't a rant. It's a roadmap. What We Cover: -How the insurance business model actually works (it's not the version in the commercial) -Prior authorization: why 80% of appealed denials are overturned — and why only 12% get appealed -Why doctors are leaving private practice — and not for the reasons you think -The 2025 scorecard: $1.7T in revenue, $54B in profits, $26,993 average family premium -The Pizza Shop analogy that makes the whole thing make sense -The prevention math — what a heart attack costs vs. what preventing it costs -5 things you can do today to route around a system designed to fail you Where to Find Us 🌐 Website: mdlongevitylab.com 📝 Substack: mdlongevitylab.substack.com — long-form essays 🎧 Podcast: MD Longevity Lab: Playing the Long Game — Spotify, Apple Podcasts, YouTube 📱 Instagram, Threads, TikTok, Bluesky: @MDLongevityLab ▶️ YouTube: MD Longevity Lab Ready for a 3-Hour Appointment With Your Doctor?Call or text 224-208-3720 to schedule an evidence-based longevity workup at MD Longevity Lab. 📍 1640 N Arlington Heights Rd, Ste 205, Arlington Heights, ILWe offer the testing your insurance won't cover — VO₂ max, full-body DEXA, coronary calcium scoring, comprehensive biomarker panels — and a real, three-hour sit-down with a physician who actually has time to think about your case. ⚕️ MD Longevity Lab — Play the Long Game This episode is for educational purposes only and does not constitute medical advice.

29. The Statin You Fear vs. The Peptide You Trust: The Credibility Crisis in American Healthcare

This episode is a follow-up and expansion of Vikas's recent piece in STAT News on the same topic. Mention statins at a dinner party and you'll get muscle pain, brain fog, and Big Pharma conspiracies. Mention BPC-157 and suddenly everyone's an expert. The same person who won't take a drug studied in half a million humans will inject a peptide studied in fourteen — ordered from a website they found on Reddit, shipped from a warehouse they can't locate on a map. In this episode, Drs. Vikas and Nisha Patel unpack the credibility crisis at the heart of American healthcare. They walk through what the statin evidence actually shows (including the SAMSON trial finding that 90% of statin side effects are nocebo), trace the troubling patent and conflict-of-interest story behind BPC-157, and explain why our brains are wired to trust an Instagram testimonial more than a 170,000-person meta-analysis. What We Cover * Why statins are the most-studied drug class in medicine — and what the data really says * The SAMSON trial: 90% of statin side effects are nocebo * The peptides everyone's injecting (BPC-157, CJC-1295, sermorelin, ipamorelin) and where they actually came from * The BPC-157 patent story: one researcher, one company, one trial that vanished * Why "natural" is not a safety profile * The cognitive biases that make us trust anecdotes over data * Why America is uniquely vulnerable to peptide marketing * 5 questions to ask about any health claim — pharmaceutical or "natural" MD Longevity Lab is a precision longevity practice in Arlington Heights, IL, founded by Dr. Vikas Patel (board-certified emergency medicine, former U.S. Navy Flight Surgeon) and Dr. Nisha Patel. We offer VO₂ max testing, full-body DEXA, comprehensive biomarker panels, evidence-based precision medicine, and three-hour physician consultations. 📞 Call or text: 224-208-3720📍 1640 N Arlington Heights Rd, Ste 205, Arlington Heights, IL 🌐 mdlongevitylab.com [http://mdlongevitylab.com] 📝 mdlongevitylab.substack.com [http://mdlongevitylab.substack.com] 📱 @MDLongevityLab on Instagram, Threads, TikTok, Bluesky ▶️ YouTube: MD Longevity Lab

28. Can You Out-Run Your Cocktail? Exercise, Alcohol, and the Science of Damage Control

Episode Title: Can You Out-Run Your Cocktail? Exercise, Alcohol, and the Science of Damage Control Can exercise protect you from the damage alcohol does to your body? Drs. Vikas and Nisha Patel break down the latest peer-reviewed data — including the 2025 HUNT study that found fit drinkers outlive sedentary abstainers — and give you the practical playbook for drinking smarter. Full Description: Alcohol is a Group 1 carcinogen. It wrecks your sleep, damages your liver, and the old "red wine is good for your heart" story was built on flawed science. So where does that leave those of us who enjoy a glass of wine at dinner or a cocktail on vacation? In this episode, Drs. Vikas and Nisha Patel dig into one of the most-requested topics from listeners: can exercise actually offset the health consequences of drinking? They walk through the most important recent research — the 2025 Norwegian HUNT study, the British Journal of Sports Medicine pooled analysis, the UK Biobank data, and a major 2025 Journal of Hepatology paper on liver-specific protection — and translate the findings into clear, practical guidance. Spoiler: exercise doesn't erase alcohol's damage. But the protective effect is real, measurable, and bigger than most people realize. Fitness turns out to be one of the single most powerful modifiers of alcohol-related risk — especially for women, who face disproportionate harm from alcohol but also derive disproportionate benefit from staying active. The Patels also get personal, sharing their own evolving relationship with alcohol, why they're not prohibitionists, and why the longevity crowd that never eats out and lives by their sleep score might be missing the point. In this episode: * What alcohol actually does to your body (cancer, sleep, liver, heart, brain) * Why the "red wine protects your heart" story fell apart * The 2025 HUNT study — fit drinkers vs. sedentary abstainers * How much exercise you need for the protective effect to kick in * Why women face higher risk — and get bigger benefit from fitness * The evolutionary mismatch lens on alcohol and movement * A 7-point practical playbook for drinking smarter Timestamps:(00:00) Cold open — and why we're covering this(01:30) What alcohol actually does to your body(03:00) Cancer risk — the conversation nobody has at cocktail hour(04:30) Sleep disruption and the REM rebound effect(06:00) Liver disease and why women are more vulnerable(07:30) The red wine myth, explained(10:00) The million-dollar question — can exercise protect you?(11:00) The 2025 HUNT study breakdown(16:00) Important caveats and study limitations(19:00) British Journal of Sports Medicine pooled analysis(21:00) UK Biobank data on heavy drinkers(23:00) Liver-specific protection — the Journal of Hepatology findings(26:00) Alcohol use disorder and exercise — the Mass General Brigham study(28:00) The evolutionary mismatch angle(34:00) Seven practical takeaways(42:00) The 30-second elevator pitch(44:00) Outro Connect with us:Website: mdlongevitylab.comSubstack: mdlongevitylab.substack.comInstagram / Threads / TikTok / Bluesky: @MDLongevityLabYouTube: MD Longevity Lab If this episode was useful, share it with someone who needs to hear it and leave us a review. It genuinely helps more people find the show. This episode is for educational purposes and is not medical advice. Talk to your physician about decisions regarding alcohol use and exercise, especially if you have underlying health conditions.

27. GLP-1 Series, Part 2: Muscle Loss, Weight Regain, and the Protocol That Actually Works

The real conversation about GLP-1 medications doesn't end with the prescription. Part 2 is where we get into the uncomfortable truths — the data on muscle loss, the biology of weight regain, the patient safety crisis hiding in the compounding pharmacy space — and more importantly, the complete five-pillar protocol for using these drugs with a long-game mentality. If you're on these medications, considering them, or prescribing them, this episode is required listening. Part 1 drops alongside this one — start there if you haven't. In this episode * Why 39% of weight lost on semaglutide may be lean mass — and what that means for your longevity trajectory * The muscle-longevity math: how GLP-1-driven sarcopenia can silently trade one risk for another * Protein targets that actually matter: why the RDA is useless and what 1.6–2.4g/kg actually looks like on a plate * The leucine threshold — why hitting 25–30g per meal is the trigger for muscle protein synthesis * Resistance training as non-negotiable: the 2023 data showing body recomposition is achievable on these drugs * The five-pillar MD Longevity Lab protocol: DEXA, protein architecture, resistance training, metabolic biomarkers, and the full clinical picture * STEP 4 trial: two-thirds of lost weight regained within one year of stopping — and why that's biology, not failure * The homeostatic counter-response: ghrelin, leptin, metabolic rate suppression, and why stopping without a foundation is dangerous * Perimenopause intersection: two simultaneous catabolic forces and why nobody is connecting the dots for women 📝 Go deeper every week: mdlongevitylab.substack.com🌐 mdlongevitylab.com — virtual and in-person consultations available📸 @mdlongevitylab🎧 Subscribe, leave a 5-star review, and send this to someone whose provider handed them a GLP-1 prescription in a three-minute visit and called it care.

26. GLP-1 Series, Part 1: The Biology, the Drugs, and Why the Benefits Go Deeper Than the Scale

📝 Free Substack: mdlongevitylab.substack.com🌐 mdlongevitylab.com📸 @mdlongevitylab🎧 Subscribe, leave a 5-star review, and share this episode with one person who needs to hear it.GLP-1 medications are genuinely revolutionary — and genuinely misunderstood. The real conversation isn't hype or panic. In Part 1, we cover the evolutionary biology behind why these drugs work so powerfully, the full drug landscape from semaglutide to retatrutide, how to actually use the new oral pill formats correctly, and the systemic benefits that go far beyond the number on the scale. Part 2 drops alongside this one — don't skip it. In this episode Why our hunger biology was never built for the modern food environment — and what that means for obesity treatment Semaglutide, tirzepatide, and retatrutide — the generation-by-generation breakdown, trial data, and side effect profile Oral meds: why the 30-minute fasting window is pharmacologically non-negotiable SELECT trial: 20% reduction in heart attacks and strokes — in patients without diabetes Kidney protection, liver healing, sleep apnea, the Alzheimer's signal, and addiction medicine — what the evidence actually shows "Food noise" isn't a metaphor — it's visible on brain MRI, and these drugs quiet it measurably.